EIR TEVA Pharmaceuticals USA Mar 2012

Douglas Kovacs FDA$595.00 - Available Now

FDA investigators audited the TEVA Pharmaceuticals USA - Fairfield, NJ, United States facility and issued inspectional observation (via FDA 483) on 30 Mar 2012.

Product details

  • Category:
  • Inspection end: 30 Mar 2012
  • Location: Fairfield, United States
  • FEI: 2245641
Add To Cart